A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma

Annals of Surgery

Volumn 245, Issue 2, 2007, Pages 187-200

  Diener, Markus K ^a,b   Knaebel, Hanns Peter ^a   Heukaufer, Christina ^a   Antes, Gerd ^b   Büchler, Markus W ^a   Seiler, Christoph M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL PARAMETERS; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONFIDENCE INTERVAL; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; META ANALYSIS; MORBIDITY; MORTALITY; OPERATION DURATION; OUTCOME ASSESSMENT; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; PERIAMPULLARY CARCINOMA; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PYLORUS; PYLORUS PRESERVING PANCREATICODUODENECTOMY; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RANDOMIZATION; REVIEW; SURGICAL TECHNIQUE; SURVIVAL; SYSTEMATIC REVIEW;

AMPULLA OF VATER; HUMANS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PYLORUS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33846409056     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000242711.74502.a9     Document Type: Review

References (58)

1. Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94:2766-2792.
2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
3. Sperti C, Pasquali C, Piccoli A, et al. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg. 1996;83:625-631.
4. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg. 1995;221: 721-731.
5. Lillemoe KD, Yeo CJ, Cameron JL. Pancreatic cancer: state-of-the-art care. CA Cancer J Clin. 2000;50:241-268.
6. Buchler MW, Wagner M, Schmied BM, et al. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg. 2003;138:1310-1314.
7. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg. 1990;211:447-458.
8. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226:248-257.
9. Bassi C, Falconi M, Salvia R, et al. Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients. Dig Surg. 2001;18:453-457.
10. Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786-795.
11. Richter A, Niedergethmann M, Sturm JW, et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg. 2003;27:324-329.
12. Kausch W. Das Carcinom der Papilla duodeni und seine radikale Entfernung. Beitr klin Chir. 1912;78:439-486.
13. Whipple AO. Treatment of carcinoma of the ampulla of Vater. Ann Surg. 1935;102:763-779.
14. Watson K. Carcinoma of the ampulla of Vater: successful radical resection. Br J Surg. 1944;31:368-373.
15. Traverso LW, Longmire WP Jr. Preservation of the pylorus in pancreaticoduodenectomy a follow-up evaluation. Ann Surg. 1980;192:306-310.
16. Trede M, Carter DC. Surgery of the Pancreas. Edinburgh: Churchill Livingstone, 1993.
17. Seiler CA, Wagner M, Sadowski C, et al. Randomized prospective trial of pylorus-preserving vs. Classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg. 2000;4:443-452.
18. Williamson RC, Bliouras N, Cooper MJ, et al. Gastric emptying and enterogastric reflux after conservative and conventional pancreatoduodenectomy. Surgery. 1993;114:82-86.
19. Horstmann O, Markus PM, Ghadimi MB, et al. Pylorus preservation has no impact on delayed gastric emptying after pancreatic head resection. Pancreas. 2004;28:69-74.
20. Wenger FA, Jacobi CA, Haubold K, et al. Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma: preliminary results of a prospective randomized study: pancreatoduodenectomy or pylorus-preserving pancreatoduodenectomy. Chirurg. 1999;70:1454-1459.
21. Warshaw AL, Torchiana DL. Delayed gastric emptying after pyloruspreserving pancreaticoduodenectomy. Surg Gynecol Obstet. 1985;160: 1-4.
22. Roder JD, Stein HJ, Huttl W, et al. Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg. 1992;79:152-155.
23. Park YC, Kim SW, Jang JY, et al. Factors influencing delayed gastric emptying after pylorus-preserving pancreatoduodenectomy. J Am Coll Surg. 2003;196:859-865.
24. Bhandari M, Devereaux PJ, Montori V, et al. Users' guide to the surgical literature: how to use a systematic literature review and meta-analysis. Can J Surg. 2004;47:60-67.
25. Higgins J, Green S (Eds). Cochrane Handbook of Systematic Reviews of Interventions, 4. 2.5 [updated May 2005]. Chichester, UK: John Wiley & Sons, 2005.
26. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
27. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
28. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896-1900.
29. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-2834.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
31. DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Stat Med. 1987;6:341-350.
32. Lin PW, Shan YS, Lin YJ, et al. Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology. 2005;52:1601-1604.
33. Seiler CA, Wagner M, Bachmann T, et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg. 2005;92:547-556.
34. Tran KT, Smeenk HG, van Eijck CH, et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg. 2004;240:738-745.
35. Bloechle C, Broering DC, Latuske C, et al. Prospective randomized study to evaluate quality of life after partial pancreatoduodenectomy according to Whipple versus pylorus preserving pancreatoduodenectomy according to Longmire-Traverso for periampullary carcinoma. Dtsch Gesellschaft Chir. 1999;(suppl 1):661-664.
36. Paquet K-J. Vergleich der partiellen Duodenopankreatektomie (Whipple-Operation) mit der pyloruserhaltenden Zephaloduodenopankreatektomie: eine prospektive kontrollierte, randomisierte Langzeitstudie. Chir Gastroenterol. 1998;14:54-58.
37. Bassi C, Stocken DD, Olah A, et al. Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Dig Surg. 2005;22:353-363.
38. Neoptolemos JP, Stocken DD, Dunn JA, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234:758-768.
39. Mosca F, Giulianotti PC, Balestracci T, et al. Long-term survival in pancreatic cancer: pylorus-preserving versus Whipple pancreatoduodenectomy. Surgery. 1997;122:553-566.
40. Egger M, Smith GD. Meta-analysis: potentials and promise. BMJ. 1997;315:1371-1374.
41. Mulrow CD. Rationale for systematic reviews. BMJ. 1994;309:597-599.
42. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8-13.
43. Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg. 1999;229:613-622.
44. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236:355-366.
45. Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005;138:618-628.
46. Bell RH Jr. Pancreaticoduodenectomy with or without pylorus preservation have similar outcomes. Cancer Treat Rev. 2005;31:328-331.
47. Wagner M, Redaelli C, Lietz M, et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91:586-594.
48. Nguyen TC, Sohn TA, Cameron JL, et al. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg. 2003;7:1-9.
49. Shan YS, Sy ED, Lin PW. Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial. World J Surg. 2003;27:709-714.
50. Lin PW, Lin YJ. Prospective randomized comparison between pyloruspreserving and standard pancreaticoduodenectomy. Br J Surg. 1999;86:603-607.
51. Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg. 1998;228:508-517.
52. Berge Henegouwen MI, Moojen TM, van Gulik TM, et al. Postoperative weight gain after standard Whipple's procedure versus pylorus-preserving pancreatoduodenectomy: the influence of tumour status. Br J Surg. 1998;85:922-926.
53. Chou FF, Sheen-Chen SM, Chen YS, et al. Postoperative morbidity and mortality of pancreaticoduodenectomy for periampullary cancer. Eur J Surg. 1996;162:477-481.
54. Brennan MF, Pisters PW, Posner M, et al. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg. 1994;220:436-441.
55. Friess H, Klempa I, Hermanek P, et al. Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Germany. Digestion. 1994;55(suppl 1):35-40.
56. Bassi C, Falconi M, Lombardi D, et al. Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy: Italian Study Group. Digestion. 1994;55(suppl 1):41-47.
57. Johnstone PA, Sindelar WF. Lymph node involvement and pancreatic resection: correlation with prognosis and local disease control in a clinical trial. Pancreas. 1993;8:535-539.
58. Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery: risk factors influencing the shortterm results. Ann Surg. 1993;217:356-368.